An interventional study of Exercise in Poly Cystic Ovary Syndrome, sponsored by British University In Egypt. Active, not recruiting at 1 site in Egypt. Open to female participants aged 20 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.
Sponsored by British University In Egypt · Not applicable, Interventional, and Treatment
Inspiratory muscle training (IMT) is a relatively simple and accessible form of exercise that specifically targets the respiratory muscles and has been reported to improve inspiratory muscle strength, respiratory efficiency, exercise capacity, and autonomic cardiovascular regulation in different populations. Given the close relationship between respiratory muscle function, exercise capacity, autonomic regulation, and metabolic health, IMT may represent a potentially useful adjunctive intervention for women with PCOS. Therefore, investigating the effects of inspiratory muscle training on relevant metabolic, functional, and clinical outcomes in women with PCOS may provide an additional therapeutic approach within physiotherapy and lifestyle-based management.
975 studies on the registry are indexed under Polycystic Ovary Syndrome; 177 are open to participants now.
This study's planned enrollment of 40 is below the median of 70 across 710 interventional studies indexed under Polycystic Ovary Syndrome.
Browse Polycystic Ovary Syndrome studies →British University In Egypt is the lead sponsor of 69 studies on the registry; 21 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants performed inspiratory muscle training using a The POWER breathe equipment (POWER breathe International Ltd.) at 50% of maximal inspiratory pressure (MIP). Training consisted of two sets of 30 inspiratory efforts per day, performed 5 days per week for 8 weeks. MIP was reassessed weekly, and the training resistance was adjusted to maintain an intensity corresponding to 50% of the current MIP. Participants performed the training in a standardized seated position following standardized breathing instructions.
Other: Exercise
Participants allocated to the sham group used the same threshold inspiratory loading device with the inspiratory resistance set at 10% of MIP. They performed the same training schedule as the intervention group (two sets of 30 inspiratory efforts per day, 5 days per week for 8 weeks) and received identical instructions and follow-up procedures. The sham resistance was maintained at a minimal level insufficient to induce a meaningful inspiratory muscle-training stimulus.
Other: Exercise
Training consisted of two sets of 30 inspiratory efforts per day, performed 5 days per week for 8 weeks. MIP was reassessed weekly, and the training resistance was adjusted to maintain an intensity corresponding to 50% of the current MIP. Participants performed the training in a standardized seated position following standardized breathing instructions.
Homeostatic model assessment of IR (HOMA- IR),
Time frame: 8 weeks
Hormonal profile (FSH, LH, FSH-LH ratio)
Time frame: 8 weeks
Serum triglyceride (TG)
Time frame: 8 weeks
HDL
Time frame: 8 weeks
LDL
Time frame: 8 weeks
Plan to share: Undecided
Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 1 month after the start.
Of 206 non-industry interventional studies with no phase under Polycystic Ovary Syndrome, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 35. This study's planned 1 month is below that.
Counting every sponsor, half of 221 studies reached it within 18 months; a quarter within 7 and three quarters within 35.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
British University In Egypt